Loading…
Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration
Background. Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle. Methods and Results. To determine myocardial hypoperfusion reversibility and its influence on segmental and global function,...
Saved in:
Published in: | Journal of nuclear cardiology 1998-09, Vol.5 (5), p.469-476 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3 |
container_end_page | 476 |
container_issue | 5 |
container_start_page | 469 |
container_title | Journal of nuclear cardiology |
container_volume | 5 |
creator | Peix, Amalia Lòpez, Adlin Ponce, Felizardo Morales, Jorge de la Vega, Adolfo Rodrìguez Chesa, Catalina Sin Maltas, Ana Ma Garcìa-Barreto, David |
description | Background. Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle.
Methods and Results. To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress
99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on
201TI imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and
99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between
99mTc-tetrofosmin and
201TI imaging.
Conclusion. Nitroglycerin administration during
99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction. |
doi_str_mv | 10.1016/S1071-3581(98)90177-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70008188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1071358198901775</els_id><sourcerecordid>2097875471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3</originalsourceid><addsrcrecordid>eNqFkc2K1jAUhoso4zh6CQNBQXRRTdqmSVYiw_gDAy7UdUiTk34Z2qQm6UBvyas0ne_ThSCuEjjP-yacp6ouCX5DMOnffiWYkbqlnLwS_LXAhLGaPqjOCW2buqeUPCz338jj6klKtxhj0QpxVp0JJnou2vPq57U_KK_BIAMZdHbBo2BRhDuIyQ0ToHkLWkXj1IQO2xIWiHZNOzZsqCQOHrJbZyTEXGfIMdiQZueRm9Xo_IiUN8i6mHK9qJRQVKZkVz05A2U2ujBGtRw2pGyGiLwrDeO0aYilQ5nS5FKOav_X0-qRVVOCZ6fzovr-4frb1af65svHz1fvb2rdEZpr2lClMVeWYc4V7kArLijVDQBprGh0o3Q3cG3EoDAfhq41wLpB95RQIFy3F9XLY-8Sw48VUpazSxqmSXkIa5KsrJETzgv4_C_wNqzRl79J1nY9xpR3BXrxL6hhnDVt3wpWKHqkdAwpRbByiWWDcZMEy123vNctd5dScHmvW9KSuzy1r8MM5k_q5LfM3x3nUBZ25yDKpB3svl0stqUJ7j8v_AID_78x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734600584</pqid></control><display><type>article</type><title>Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration</title><source>Springer Nature</source><creator>Peix, Amalia ; Lòpez, Adlin ; Ponce, Felizardo ; Morales, Jorge ; de la Vega, Adolfo Rodrìguez ; Chesa, Catalina Sin ; Maltas, Ana Ma ; Garcìa-Barreto, David</creator><creatorcontrib>Peix, Amalia ; Lòpez, Adlin ; Ponce, Felizardo ; Morales, Jorge ; de la Vega, Adolfo Rodrìguez ; Chesa, Catalina Sin ; Maltas, Ana Ma ; Garcìa-Barreto, David</creatorcontrib><description>Background. Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle.
Methods and Results. To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress
99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on
201TI imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and
99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between
99mTc-tetrofosmin and
201TI imaging.
Conclusion. Nitroglycerin administration during
99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction.</description><identifier>ISSN: 1071-3581</identifier><identifier>EISSN: 1532-6551</identifier><identifier>DOI: 10.1016/S1071-3581(98)90177-5</identifier><identifier>PMID: 9796893</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Coronary Circulation ; Female ; first-pass radionuclide angiography ; Heart - diagnostic imaging ; Heart attacks ; Humans ; Male ; Medical imaging ; Middle Aged ; Myocardial Infarction - diagnostic imaging ; myocardial scintigraphy ; nitroglycerin ; Nitroglycerin - pharmacology ; Organophosphorus Compounds ; Organotechnetium Compounds ; Radionuclide Angiography ; Scintigraphy ; tetrofosmin ; Thallium Radioisotopes ; Vasodilator Agents - pharmacology</subject><ispartof>Journal of nuclear cardiology, 1998-09, Vol.5 (5), p.469-476</ispartof><rights>1998</rights><rights>the American Society of Nuclear Cardiology 1998.</rights><rights>American Society of Nuclear Cardiology 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3</citedby><cites>FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9796893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peix, Amalia</creatorcontrib><creatorcontrib>Lòpez, Adlin</creatorcontrib><creatorcontrib>Ponce, Felizardo</creatorcontrib><creatorcontrib>Morales, Jorge</creatorcontrib><creatorcontrib>de la Vega, Adolfo Rodrìguez</creatorcontrib><creatorcontrib>Chesa, Catalina Sin</creatorcontrib><creatorcontrib>Maltas, Ana Ma</creatorcontrib><creatorcontrib>Garcìa-Barreto, David</creatorcontrib><title>Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration</title><title>Journal of nuclear cardiology</title><addtitle>J Nucl Cardiol</addtitle><description>Background. Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle.
Methods and Results. To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress
99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on
201TI imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and
99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between
99mTc-tetrofosmin and
201TI imaging.
Conclusion. Nitroglycerin administration during
99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction.</description><subject>Adult</subject><subject>Aged</subject><subject>Coronary Circulation</subject><subject>Female</subject><subject>first-pass radionuclide angiography</subject><subject>Heart - diagnostic imaging</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>myocardial scintigraphy</subject><subject>nitroglycerin</subject><subject>Nitroglycerin - pharmacology</subject><subject>Organophosphorus Compounds</subject><subject>Organotechnetium Compounds</subject><subject>Radionuclide Angiography</subject><subject>Scintigraphy</subject><subject>tetrofosmin</subject><subject>Thallium Radioisotopes</subject><subject>Vasodilator Agents - pharmacology</subject><issn>1071-3581</issn><issn>1532-6551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkc2K1jAUhoso4zh6CQNBQXRRTdqmSVYiw_gDAy7UdUiTk34Z2qQm6UBvyas0ne_ThSCuEjjP-yacp6ouCX5DMOnffiWYkbqlnLwS_LXAhLGaPqjOCW2buqeUPCz338jj6klKtxhj0QpxVp0JJnou2vPq57U_KK_BIAMZdHbBo2BRhDuIyQ0ToHkLWkXj1IQO2xIWiHZNOzZsqCQOHrJbZyTEXGfIMdiQZueRm9Xo_IiUN8i6mHK9qJRQVKZkVz05A2U2ujBGtRw2pGyGiLwrDeO0aYilQ5nS5FKOav_X0-qRVVOCZ6fzovr-4frb1af65svHz1fvb2rdEZpr2lClMVeWYc4V7kArLijVDQBprGh0o3Q3cG3EoDAfhq41wLpB95RQIFy3F9XLY-8Sw48VUpazSxqmSXkIa5KsrJETzgv4_C_wNqzRl79J1nY9xpR3BXrxL6hhnDVt3wpWKHqkdAwpRbByiWWDcZMEy123vNctd5dScHmvW9KSuzy1r8MM5k_q5LfM3x3nUBZ25yDKpB3svl0stqUJ7j8v_AID_78x</recordid><startdate>19980901</startdate><enddate>19980901</enddate><creator>Peix, Amalia</creator><creator>Lòpez, Adlin</creator><creator>Ponce, Felizardo</creator><creator>Morales, Jorge</creator><creator>de la Vega, Adolfo Rodrìguez</creator><creator>Chesa, Catalina Sin</creator><creator>Maltas, Ana Ma</creator><creator>Garcìa-Barreto, David</creator><general>Elsevier Inc</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19980901</creationdate><title>Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration</title><author>Peix, Amalia ; Lòpez, Adlin ; Ponce, Felizardo ; Morales, Jorge ; de la Vega, Adolfo Rodrìguez ; Chesa, Catalina Sin ; Maltas, Ana Ma ; Garcìa-Barreto, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Coronary Circulation</topic><topic>Female</topic><topic>first-pass radionuclide angiography</topic><topic>Heart - diagnostic imaging</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>myocardial scintigraphy</topic><topic>nitroglycerin</topic><topic>Nitroglycerin - pharmacology</topic><topic>Organophosphorus Compounds</topic><topic>Organotechnetium Compounds</topic><topic>Radionuclide Angiography</topic><topic>Scintigraphy</topic><topic>tetrofosmin</topic><topic>Thallium Radioisotopes</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peix, Amalia</creatorcontrib><creatorcontrib>Lòpez, Adlin</creatorcontrib><creatorcontrib>Ponce, Felizardo</creatorcontrib><creatorcontrib>Morales, Jorge</creatorcontrib><creatorcontrib>de la Vega, Adolfo Rodrìguez</creatorcontrib><creatorcontrib>Chesa, Catalina Sin</creatorcontrib><creatorcontrib>Maltas, Ana Ma</creatorcontrib><creatorcontrib>Garcìa-Barreto, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of nuclear cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peix, Amalia</au><au>Lòpez, Adlin</au><au>Ponce, Felizardo</au><au>Morales, Jorge</au><au>de la Vega, Adolfo Rodrìguez</au><au>Chesa, Catalina Sin</au><au>Maltas, Ana Ma</au><au>Garcìa-Barreto, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration</atitle><jtitle>Journal of nuclear cardiology</jtitle><addtitle>J Nucl Cardiol</addtitle><date>1998-09-01</date><risdate>1998</risdate><volume>5</volume><issue>5</issue><spage>469</spage><epage>476</epage><pages>469-476</pages><issn>1071-3581</issn><eissn>1532-6551</eissn><abstract>Background. Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle.
Methods and Results. To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress
99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on
201TI imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and
99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between
99mTc-tetrofosmin and
201TI imaging.
Conclusion. Nitroglycerin administration during
99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>9796893</pmid><doi>10.1016/S1071-3581(98)90177-5</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1071-3581 |
ispartof | Journal of nuclear cardiology, 1998-09, Vol.5 (5), p.469-476 |
issn | 1071-3581 1532-6551 |
language | eng |
recordid | cdi_proquest_miscellaneous_70008188 |
source | Springer Nature |
subjects | Adult Aged Coronary Circulation Female first-pass radionuclide angiography Heart - diagnostic imaging Heart attacks Humans Male Medical imaging Middle Aged Myocardial Infarction - diagnostic imaging myocardial scintigraphy nitroglycerin Nitroglycerin - pharmacology Organophosphorus Compounds Organotechnetium Compounds Radionuclide Angiography Scintigraphy tetrofosmin Thallium Radioisotopes Vasodilator Agents - pharmacology |
title | Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20detection%20of%20reversible%20myocardial%20hypoperfusion%20by%20technetium%2099m-tetrofosmin%20imaging%20and%20first-pass%20radionuclide%20angiography%20after%20nitroglycerin%20administration&rft.jtitle=Journal%20of%20nuclear%20cardiology&rft.au=Peix,%20Amalia&rft.date=1998-09-01&rft.volume=5&rft.issue=5&rft.spage=469&rft.epage=476&rft.pages=469-476&rft.issn=1071-3581&rft.eissn=1532-6551&rft_id=info:doi/10.1016/S1071-3581(98)90177-5&rft_dat=%3Cproquest_cross%3E2097875471%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-525ac08af7088a04eca8955c2ee12f92c2ac4b8cd9ba08bb43de74bc6515e18c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734600584&rft_id=info:pmid/9796893&rfr_iscdi=true |